Log in to save to my catalogue

Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome

Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2042750567

Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome

About this item

Full title

Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2018-06, Vol.24 (6), p.802-813

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is caused by mutations in
ATRX
, which encodes a chromatin-remodeling protein. Genome-wide analyses in mouse and human cells indicate that ATRX tends to bind to G-rich sequences with a high potential to form G-quadruplexes. Here, we report that
Atrx
mutation induces abe...

Alternative Titles

Full title

Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2042750567

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2042750567

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-018-0018-6

How to access this item